http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Comparative Analysis of Multi-Cultural Situations Between Korea and Germany
Hyeong-Min Kim(김형민),Min-Su Lee,Sang-Bum Chin 전북대학교 국제문화교류연구소 2013 전북대학교 국제문화교류연구소 심포지움 Vol.2013 No.12
Now Korea where a homogeneous culture has been relatively enjoyed is entering a multi-cultural society, facing challenges caused by the influx of heterogeneous culture(s) together with the immigrant workers, immigrant spouses, refugees from North Korea etc. To cope with challenges wisely we should try to formulate and implement ways to improve social unity. This paper intends to offer some suggestions for the implementation of desirable policies by conducting a comparative study on the case of Germany which had its multi-cultural experiences earlier than Korea.
Seok Hyeri,Park Dae Won,Kim Kwang Nam,Kim Min Ja,Kim Sung-Han,Kim Jeong Yeon,Park Su Eun,Park Se Yoon,Eun Byung Wook,Lee Mi Suk,장현하,Jung Hyungul,Jeong Hye Won,Jo Soo-Nam,Chin Bum Sik,Choi Young Hwa,Ch 대한감염학회 2021 Infection and Chemotherapy Vol.53 No.3
During the 2019 domestic measles outbreak in Korea, measles occurred in healthcare workers with two doses of the measles, mumps and rubella vaccine, and the strict application of the Occupational Safety and Health Act required medical institutions to identify healthcare workers' immunity to measles and vaccinate the susceptible pockets. In response to the frontline medical institutions' request to review the measles recommendations and guidelines, the Korean Society of Infectious Diseases held a roundtable discussion on the causes of measles outbreak, timing of vaccinations, antibody tests, and booster vaccinations for healthcare workers, and financial support from the government and municipality as well as response strategies against the outbreak in healthcare settings. In Korea, the seroprevalence of measles is decreasing in the vaccine-induced immunity group during the maintenance of measles elimination over several years. The susceptible group against measles is in their 20s and 30s, and this may be because of waning immunity rather than non-response considering Korea's vaccine policy. The risk of measles nosocomial infection from community increases as these susceptible pockets actively engage in medical institutions. Thus, data on the immunity of low seroprevalence group in Korea are needed, further discussion is needed on the booster vaccination based on the data. Especially, antibody testing and vaccination in healthcare workers may be necessary to prevent the spread of measles in medical insutitutions, and further discussion is needed regarding specific testing methods, and the timing and frequency of test and vaccination.
( Mi Ryoung Seo ),( Ji-won Kim ),( Eun-jung Park ),( Seung Min Jung ),( Yoon-kyoung Sung ),( Hyungjin Kim ),( Gunwoo Kim ),( Hyun-sook Kim ),( Myeung-su Lee ),( Jisoo Lee ),( Jian Hur ),( Bum Sik Chin 대한류마티스학회 2020 대한류마티스학회지 Vol.27 No.4
Patients with systemic rheumatic diseases (SRD) are vulnerable for coronavirus disease (COVID-19). The Korean College of Rheumatology recognized the urgent need to develop recommendations for rheumatologists and other physicians to manage patients with SRD during the COVID-19 pandemic. The working group was organized and was responsible for selecting key health questions, searching and reviewing the available literature, and formulating statements. The appropriateness of the statements was evaluated by voting panels using the modified Delphi method. Four general principles and thirteen individual recommendations were finalized through expert consensus based on the available evidence. The recommendations included preventive measures against COVID-19, medicinal treatment for stable or active SRD patients without COVID-19, medicinal treatment for SRD patients with COVID-19, and patient evaluation and monitoring. Medicinal treatments were categorized according to the status with respect to both COVID-19 and SRD. These recommendations should serve as a reference for individualized treatment for patients with SRD. As new evidence is emerging, an immediate update will be required. (J Rheum Dis 2020;27:218-232)